产品中心PRODUCT CENTER
全国热线：027-87561633
| 位置 | 性别 | 年龄 | 标本部位 | 病理分类 | 病理分级 | TNM_T | TNM_N | TNM_M |
| A1,B1 | F | 47 | 乳腺 | 正常 | / | / | / | / |
| A2,B2 | F | 40 | 乳腺 | 正常 | / | / | / | / |
| A3,B3 | F | 38 | 乳腺 | 增生 | / | / | / | / |
| A4,B4 | F | 50 | 乳腺 | 增生 | / | / | / | / |
| A5,B5 | F | 52 | 乳腺 | 增生 | / | / | / | / |
| A6,B6 | F | 45 | 乳腺 | 增生 | / | / | / | / |
| A7,B7 | F | 32 | 乳腺 | 不典型增生 | / | / | / | / |
| A8,B8 | F | 35 | 乳腺 | 纤维囊性乳腺病 | / | / | / | / |
| A9,B9 | F | 40 | 乳腺 | 纤维囊性乳腺病 | / | / | / | / |
| A10,B10 | F | 50 | 乳腺 | 纤维囊性乳腺病 | / | / | / | / |
| A11,B11 | F | 40 | 乳腺 | 纤维囊性乳腺病 | / | / | / | / |
| A12,B12 | F | 23 | 乳腺 | 纤维腺瘤 | / | / | / | / |
| C1,D1 | F | 45 | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| C2,D2 | F | 42 | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| C3,D3 | F | 32 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| C4,D4 | F | 48 | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| C5,D5 | F | 46 | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| C6,D6 | F | 34 | 乳腺 | 浸润性小叶癌 | II | T2 | N0 | M0 |
| C7,D7 | F | 53 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| C8,D8 | F | 44 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| C9,D9 | F | 70 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| C10,D10 | F | 52 | 乳腺 | 导管内癌 | I | Tis | N0 | M0 |
| C11,D11 | F | 68 | 乳腺 | 浸润性导管癌 | II~III | T3 | N0 | M0 |
| C12,D12 | F | 52 | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| E1,F1 | F | 59 | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| E2,F2 | F | 40 | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| E3,F3 | F | 45 | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| E4,F4 | F | 86 | 乳腺 | 浸润性大汗腺癌 | III | T2 | N0 | M0 |
| E5,F5 | F | 35 | 乳腺 | 浸润性小叶癌 | I | T2 | N1 | M0 |
| E6,F6 | F | 44 | 乳腺 | 浸润性管状腺癌 | I | T2 | N1 | M0 |
| E7,F7 | F | 54 | 乳腺 | 浸润性导管癌 | II | T1 | N0 | M0 |
| E8,F8 | F | 40 | 乳腺 | 浸润性导管癌 | I | T2 | N0 | M0 |
| E9,F9 | F | 50 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| E10,F10 | F | 71 | 乳腺 | 浸润性导管癌 | III | T4 | N0 | M0 |
| E11,F11 | F | 43 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| E12,F12 | F | 52 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| G1,H1 | F | 54 | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| G2,H2 | F | 40 | 乳腺 | 浸润性导管癌 | I | T2 | N1 | M0 |
| G3,H3 | F | 76 | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| G4,H4 | F | 39 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| G5,H5 | F | 72 | 乳腺 | 浸润性导管癌 | II | T4 | N0 | M0 |
| G6,H6 | F | 35 | 乳腺 | 浸润性导管癌 | I | T3 | N1 | M0 |
| G7,H7 | F | 60 | 乳腺 | 浸润性导管癌 | I | T2 | N0 | M0 |
| G8,H8 | F | 37 | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| G9,H9 | F | 53 | 乳腺 | 浸润性导管癌 | II | T3 | N0 | M0 |
| G10,H10 | F | 52 | 乳腺 | 浸润性小叶癌 | I | T1 | N0 | M0 |
| G11,H11 | F | 71 | 乳腺 | 浸润性导管癌 | II | T1 | N0 | M0 |
| G12,H12 | F | 70 | 乳腺 | 浸润性导管癌 | I | T1 | N0 | M0 |
027-87561633
121545059@qq.com
武汉东湖新技术开发区高新大道666号光谷生物城生物创新园B1栋b274-9室